domingo, 19 de marzo de 2017

Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease. - PubMed - NCBI

Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease. - PubMed - NCBI



 2016 Feb;74(2):166-76. doi: 10.1590/0004-282X20150194. Epub 2015 Dec 22.

Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease.

Erratum in

Abstract

Pompe disease (PD) is a potentially lethal illness involving irreversible muscle damage resulting from glycogen storage in muscle fiber and activation of autophagic pathways. A promising therapeutic perspective for PD is enzyme replacement therapy (ERT) with the human recombinant enzyme acid alpha-glucosidase (Myozyme®). The need to organize a diagnostic flowchart, systematize clinical follow-up, and establish new therapeutic recommendations has become vital, as ERT ensures greater patient longevity. A task force of experienced clinicians outlined a protocol for diagnosis, monitoring, treatment, genetic counseling, and rehabilitation for PD patients. The study was conducted under the coordination of REBREPOM, the Brazilian Network for Studies of PD. The meeting of these experts took place in October 2013, at L'Hotel Port Bay in São Paulo, Brazil. In August 2014, the text was reassessed and updated. Given the rarity of PD and limited high-impact publications, experts submitted their views.

PMID:
 
26690841
 
DOI:
 
10.1590/0004-282X20150194

[Indexed for MEDLINE] 
Free full text


From Guideline Database
This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.